Original Research

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study

Gordon D, Hellriegel ET, Hope HR, Burt D, Monahan JB

Clinical Pharmacology: Advances and Applications 2021, 13:123-134

Published Date: 10 June 2021